NeuroPace, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NPCE research report →
Companywww.neuropace.com
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source.
- CEO
- Joel D. Becker
- IPO
- 2021
- Employees
- 184
- HQ
- Mountain View, CA, US
Price Chart
Valuation
- Market Cap
- $554.71M
- P/E
- -25.44
- P/S
- 5.57
- P/B
- 37.95
- EV/EBITDA
- -41.02
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 78.29%
- Op Margin
- -16.84%
- Net Margin
- -21.67%
- ROE
- -120.74%
- ROIC
- -19.74%
Growth & Income
- Revenue
- $99.99M · 25.13%
- Net Income
- $-21,465,000 · 20.91%
- EPS
- $-0.66 · 29.03%
- Op Income
- $-16,338,000
- FCF YoY
- 37.89%
Performance & Tape
- 52W High
- $19.60
- 52W Low
- $7.56
- 50D MA
- $15.30
- 200D MA
- $13.52
- Beta
- 1.93
- Avg Volume
- 210.42K
Get TickerSpark's AI analysis on NPCE
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 15, 26 | Williams Patrick F. | other | 16,820 |
| May 15, 26 | Williams Patrick F. | other | 44,800 |
| May 15, 26 | Morrell Martha | other | 5,460 |
| May 15, 26 | Morrell Martha | other | 14,550 |
| May 15, 26 | Becker Joel | other | 45,880 |
| May 15, 26 | Becker Joel | other | 122,190 |
| Mar 24, 26 | Morrell Martha | other | 1,341 |
| Mar 20, 26 | Geiger Uri | other | 913 |
| Mar 20, 26 | LACOB JOSEPH | other | 865 |
| Mar 20, 26 | Kumar Rakhi | other | 1,153 |
Our NPCE Coverage
We haven't published any research on NPCE yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate NPCE Report →